A PHASE-II STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN), IN COMBINATION WITH (5-FU) AND CYCLOPHOSPHAMIDE (CPA) IN THE TREATMENT OFMETASTATIC BREAST-CANCER (MBC)

Authors
VALERO V AZARNIA N BUZDAR A THERIAULST R WILLEY J LEE L HORTOBAGYI G
Citation
V. Valero et al., A PHASE-II STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN), IN COMBINATION WITH (5-FU) AND CYCLOPHOSPHAMIDE (CPA) IN THE TREATMENT OFMETASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 65-65
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
65 - 65
Database
ISI
SICI code
0923-7534(1998)9:<65:APSOTD>2.0.ZU;2-B